Ramona Businger

408 total citations
18 papers, 268 citations indexed

About

Ramona Businger is a scholar working on Epidemiology, Infectious Diseases and Virology. According to data from OpenAlex, Ramona Businger has authored 18 papers receiving a total of 268 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 8 papers in Infectious Diseases and 6 papers in Virology. Recurrent topics in Ramona Businger's work include HIV Research and Treatment (6 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and Cytomegalovirus and herpesvirus research (5 papers). Ramona Businger is often cited by papers focused on HIV Research and Treatment (6 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and Cytomegalovirus and herpesvirus research (5 papers). Ramona Businger collaborates with scholars based in Germany, Belgium and Slovakia. Ramona Businger's co-authors include Michael Schindler, Natalia Ruétalo, Lüder Wiebusch, Thomas Gramberg, Jens Milbradt, Janina Auth, Ulrich S. Schubert, Pia Rauch, Johannes Solzin and Dominik Hotter and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Frontiers in Immunology and Cell Reports.

In The Last Decade

Ramona Businger

18 papers receiving 265 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ramona Businger Germany 12 106 87 63 58 54 18 268
Marshall Karpel United States 5 106 1.0× 89 1.0× 55 0.9× 76 1.3× 55 1.0× 6 288
Angeline Tilly Dang United States 9 95 0.9× 73 0.8× 141 2.2× 79 1.4× 30 0.6× 10 347
Fatima Barmania South Africa 4 74 0.7× 192 2.2× 67 1.1× 26 0.4× 36 0.7× 5 298
Karla Garcia United States 10 109 1.0× 104 1.2× 61 1.0× 41 0.7× 22 0.4× 14 286
Dominique Demonté Belgium 9 226 2.1× 111 1.3× 142 2.3× 59 1.0× 131 2.4× 10 466
Ann‐Kathrin Reuschl United Kingdom 8 140 1.3× 187 2.1× 81 1.3× 66 1.1× 11 0.2× 9 315
Tayebeh Hashempour Iran 13 58 0.5× 127 1.5× 141 2.2× 116 2.0× 123 2.3× 52 387
Masamichi Oshima Japan 10 86 0.8× 60 0.7× 61 1.0× 59 1.0× 38 0.7× 15 285
Anna Haas Switzerland 7 188 1.8× 89 1.0× 70 1.1× 75 1.3× 156 2.9× 7 325
Mariana Mesel‐Lemoine France 8 97 0.9× 113 1.3× 63 1.0× 62 1.1× 22 0.4× 9 302

Countries citing papers authored by Ramona Businger

Since Specialization
Citations

This map shows the geographic impact of Ramona Businger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ramona Businger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ramona Businger more than expected).

Fields of papers citing papers by Ramona Businger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ramona Businger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ramona Businger. The network helps show where Ramona Businger may publish in the future.

Co-authorship network of co-authors of Ramona Businger

This figure shows the co-authorship network connecting the top 25 collaborators of Ramona Businger. A scholar is included among the top collaborators of Ramona Businger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ramona Businger. Ramona Businger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Businger, Ramona, et al.. (2023). Abemaciclib restricts HCMV replication by suppressing pUL97-mediated phosphorylation of SAMHD1. Antiviral Research. 217. 105689–105689. 4 indexed citations
2.
Bayyoud, Tarek, Ramona Businger, Dan Hu, et al.. (2022). Absence of detectable SARS-CoV-2 replication in ex vivo cultured cornea and cornea-derived epithelial cells. Graefe s Archive for Clinical and Experimental Ophthalmology. 261(2). 435–446. 1 indexed citations
3.
Ruétalo, Natalia, Ramona Businger, Karina Althaus, et al.. (2021). Antibody Response against SARS-CoV-2 and Seasonal Coronaviruses in Nonhospitalized COVID-19 Patients. mSphere. 6(1). 12 indexed citations
4.
Ruétalo, Natalia, Ramona Businger, & Michael Schindler. (2021). Rapid, dose-dependent and efficient inactivation of surface dried SARS-CoV-2 by 254 nm UV-C irradiation. Eurosurveillance. 26(42). 20 indexed citations
5.
Businger, Ramona, et al.. (2021). Automated, label-free TCID50 assay to determine the infectious titer of virus-based therapeutics. Journal of Virological Methods. 299. 114318–114318. 14 indexed citations
6.
Businger, Ramona, Patrick Müller, Marius Cosmin Codrea, et al.. (2021). Comprehensive Analysis of Human Cytomegalovirus- and HIV-Mediated Plasma Membrane Remodeling in Macrophages. mBio. 12(4). e0177021–e0177021. 7 indexed citations
7.
Ruétalo, Natalia, Dan Hu, Ramona Businger, et al.. (2021). Quinine Inhibits Infection of Human Cell Lines with SARS-CoV-2. Viruses. 13(4). 647–647. 37 indexed citations
8.
Businger, Ramona, Vincent Truffault, Natalia Ruétalo, et al.. (2020). The human α-defensin-derived peptide HD5(1–9) inhibits cellular attachment and entry of human cytomegalovirus. Antiviral Research. 177. 104779–104779. 11 indexed citations
9.
Ruétalo, Natalia, Ramona Businger, Pia Rauch, et al.. (2020). Evidence That Quinine Exhibits Antiviral Activity against SARS-CoV-2 Infection In Vitro. 11 indexed citations
10.
Flehmig, Bertram, Michael Schindler, Natalia Ruétalo, et al.. (2020). Persisting Neutralizing Activity to SARS-CoV-2 over Months in Sera of COVID-19 Patients. Viruses. 12(12). 1357–1357. 10 indexed citations
11.
Flehmig, Bertram, Michael Schindler, Natalia Ruétalo, et al.. (2020). Longitudinal Analysis of Virus Load, Serum Antibody Levels and Virus Neutralizing Activity <i>In Vitro</i> in Cases with Less Severe COVID-19. SSRN Electronic Journal. 1 indexed citations
12.
Businger, Ramona, et al.. (2019). Human cytomegalovirus overcomes SAMHD1 restriction in macrophages via pUL97. Nature Microbiology. 4(12). 2260–2272. 36 indexed citations
13.
Herster, Franziska, Zsofia Bittner, Marius Cosmin Codrea, et al.. (2019). Platelets Aggregate With Neutrophils and Promote Skin Pathology in Psoriasis. Frontiers in Immunology. 10. 1867–1867. 35 indexed citations
14.
Businger, Ramona, Markus Hoffmann, Birgit Fehrenbacher, et al.. (2019). Release of Immunomodulatory Ebola Virus Glycoprotein-Containing Microvesicles Is Suppressed by Tetherin in a Species-Specific Manner. Cell Reports. 26(7). 1841–1853.e6. 13 indexed citations
15.
Dimitrov, Stoyan, Cécile Gouttefangeas, Luciana Besedovsky, et al.. (2018). Activated integrins identify functional antigen-specific CD8+T cells within minutes after antigen stimulation. Proceedings of the National Academy of Sciences. 115(24). E5536–E5545. 15 indexed citations
16.
Koppensteiner, Herwig, Ramona Businger, Stephanie Rebensburg, et al.. (2017). T cells with low CD2 levels express reduced restriction factors and are preferentially infected in therapy naïve chronic HIV‐1 patients. Journal of the International AIDS Society. 20(1). 21865–21865. 7 indexed citations
17.
Hofmann, Stephan, Ramona Businger, Martha Schneider, et al.. (2017). Dual role of the chromatin-binding factor PHF13 in the pre- and post-integration phases of HIV-1 replication. Open Biology. 7(10). 170115–170115. 11 indexed citations
18.
Höhne, Kristin, Ramona Businger, Anouk Van Nuffel, et al.. (2016). Virion encapsidated HIV-1 Vpr induces NFAT to prime non-activated T cells for productive infection. Open Biology. 6(7). 160046–160046. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marshall Karpel Breakdown of academic impact, for papers by Angeline Tilly Dang Breakdown of academic impact, for papers by Fatima Barmania Breakdown of academic impact, for papers by Karla Garcia Breakdown of academic impact, for papers by Dominique Demonté Breakdown of academic impact, for papers by Ann‐Kathrin Reuschl Breakdown of academic impact, for papers by Tayebeh Hashempour Breakdown of academic impact, for papers by Masamichi Oshima Breakdown of academic impact, for papers by Anna Haas Breakdown of academic impact, for papers by Mariana Mesel‐Lemoine
Rankless by CCL
2026